People · Operator
Named in public records as an officer, director or promoter · active 2013–2020 · Biotechnology, Pharmaceuticals, Software / Tech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prelude Therapeutics Inc | — | Biotechnology | Series C | $115.0M | $1.9B | 2016 |
| Navitor Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $68.2M | $686.4M | 2015 |
| StreetLight Data Inc. | — | Software / Tech | Series A | $40.5M | $416.1M | 2013 |
| Gocharge, Inc. | — | Other | Seed | $1.1M | $20.5M | 2014 |
| MediCool Technologies, Inc. | — | Software / Tech | Pre-Seed | $675K | $26.0M | 2020 |
Paul Friedman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Friedman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Williams | 1 | 18 |
| Jean-Francois Formela | 1 | 17 |
| Kevin Bitterman | 1 | 15 |
| Brian Gallagher | 1 | 11 |
| Alan Crane | 1 | 9 |
| Rajeev Dadoo | 1 | 7 |
| Reuben Munger | 1 | 7 |
| VEERY MAXWELL | 1 | 7 |
| David Bonita | 1 | 6 |
| John Creecy | 1 | 5 |
| Marc Singer | 1 | 5 |
| THOMAS HUGHES | 1 | 4 |
| Marian Nakada | 1 | 4 |
| Vinzenz Ploerer | 1 | 4 |
| Bill Perry | 1 | 3 |
| David Madden | 1 | 3 |
| Peter Stone | 1 | 2 |
| Mardi C. Dier | 1 | 2 |
| Scott Pinizzotto | 1 | 2 |
| Vinzenz P. Ploerer | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.